2013
DOI: 10.1126/science.341.6149.947
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

NIH Effort Gambles on Mysterious Extracellular RNAs

Abstract: A $17 million research program, announced this month by the U.S. National Institutes of Health, aims to determine whether RNA molecules are deliberately released by cells as hormonelike signals—and whether such extracellular RNAs can be harnessed for diagnosis and treatment of human diseases.

Search citation statements

Order By: Relevance

Paper Sections

Select...
11
2
1
0

Citation Types

1
8
0
0

Year Published

Range
2014
2014
2021
2021

Publication Types

Select...
14

Relationship

0
14

Authors

Journals

Cited by 14 publications

(9 citation statements)

References 0 publications

1
8
0
0
Order By: Relevance
How the paper below cites the one you are viewing
“…However, HSV-1 is well-known for its extensive ability to suppress immunity in cells that it infects (Melchjorsen et al, 2009), so SIDT2-mediated bystander activation – whereby uninfected host cells take up, detect, and respond to extracellular HSV-1 dsRNA released from infected cells – may represent an important counter strategy for host immunity. Along similar lines, recent in vitro experiments have demonstrated a role for dsRNA-based activation of bystander cells in limiting hepatitis C virus (HCV) infection (Dansako et al, 2013), but our results provide evidence that this activation is important in vivo and highlight a physiological role for extracellular RNA at a time when this is a matter of considerable interest and debate (Leslie, 2013). …”
Section: Discussion
supporting
confidence: 71%